Drug maker Roche Holding AG said on Thursday it would help generic drug makers in the developing world produce versions of HIV drug saquinavir.
Roche will offer manufacturers in sub-Saharan Africa and the world's least developed countries the technical expertise they need to make the drug, which is recommended by the World Health Organisation (WHO) to treat the virus that leads to AIDS.
Saquinavir is a protease inhibitor, one of a class of drugs that works by blocking part of the virus and preventing it from replicating.
Protease inhibitors are used in combination with other anti-HIV drugs to reduce the amount of HIV in the body.